This blog is now closed.

• Get our breaking news email, free app or daily news podcast

The health minister, Mark Butler, is holding a press conference in Adelaide to announce the endometriosis drug Visanne will be added to the pharmaceutical benefits scheme. It’s the first listing of an endo treatment in three decades.

This is a condition that impacts more than 1 million women – one in seven women and teenage girls – and for too long, too many women have been made to suffer in silence.

[They’ve] been told by many healthcare professionals, it has to be said, that this is “normal”. That it is a normal part of period pain or many other explanations for debilitating, crippling pain.

This is all about providing cheaper medicines and cutting-edge treatment to Australian patients generally, but [particularly] in the area of endometriosis, which has attracted such inadequate support for hundreds of thousands of Australian women.

This listing is beyond time.

The major contributor to the record has been the minimum temperatures, which averaged 17.2ºC over the spring season for the site, and were elevated by cloud cover, precipitation, and most notably, humidity.